BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15651539)

  • 1. Use of item response theory to develop a shortened version of the EORTC QLQ-C30 emotional functioning scale.
    Bjorner JB; Petersen MA; Groenvold M; Aaronson N; Ahlner-Elmqvist M; Arraras JI; Brédart A; Fayers P; Jordhoy M; Sprangers M; Watson M; Young T;
    Qual Life Res; 2004 Dec; 13(10):1683-97. PubMed ID: 15651539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Item response theory was used to shorten EORTC QLQ-C30 scales for use in palliative care.
    Petersen MA; Groenvold M; Aaronson N; Blazeby J; Brandberg Y; de Graeff A; Fayers P; Hammerlid E; Sprangers M; Velikova G; Bjorner JB;
    J Clin Epidemiol; 2006 Jan; 59(1):36-44. PubMed ID: 16360559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
    Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
    Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An emotional functioning item bank of 24 items for computerized adaptive testing (CAT) was established.
    Petersen MA; Gamper EM; Costantini A; Giesinger JM; Holzner B; Johnson C; Sztankay M; Young T; Groenvold M;
    J Clin Epidemiol; 2016 Feb; 70():90-100. PubMed ID: 26363341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoring based on item response theory did not alter the measurement ability of EORTC QLQ-C30 scales.
    Petersen MA; Groenvold M; Aaronson N; Brenne E; Fayers P; Nielsen JD; Sprangers M; Bjorner JB;
    J Clin Epidemiol; 2005 Sep; 58(9):902-8. PubMed ID: 16085193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation study of the Thai version.
    Silpakit C; Sirilerttrakul S; Jirajarus M; Sirisinha T; Sirachainan E; Ratanatharathorn V
    Qual Life Res; 2006 Feb; 15(1):167-72. PubMed ID: 16411041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
    Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
    Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
    Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care.
    Groenvold M; Petersen MA; Aaronson NK; Arraras JI; Blazeby JM; Bottomley A; Fayers PM; de Graeff A; Hammerlid E; Kaasa S; Sprangers MA; Bjorner JB;
    Eur J Cancer; 2006 Jan; 42(1):55-64. PubMed ID: 16162404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development.
    Gamper EM; Groenvold M; Petersen MA; Young T; Costantini A; Aaronson N; Giesinger JM; Meraner V; Kemmler G; Holzner B;
    Psychooncology; 2014 Apr; 23(4):397-403. PubMed ID: 24217943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
    Petersen MA; Groenvold M; Aaronson NK; Chie WC; Conroy T; Costantini A; Fayers P; Helbostad J; Holzner B; Kaasa S; Singer S; Velikova G; Young T;
    Eur J Cancer; 2010 May; 46(8):1352-8. PubMed ID: 20231085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses.
    Scott NW; Fayers PM; Bottomley A; Aaronson NK; de Graeff A; Groenvold M; Koller M; Petersen MA; Sprangers MA;
    Qual Life Res; 2006 Aug; 15(6):1103-15; discussion 1117-20. PubMed ID: 16900290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Korean version of the EORTC QLQ-C30.
    Yun YH; Park YS; Lee ES; Bang SM; Heo DS; Park SY; You CH; West K
    Qual Life Res; 2004 May; 13(4):863-8. PubMed ID: 15129896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.